Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review
This systematic review compares the efficacy and safety of gliclazide and glimepiride in managing type 2 diabetes mellitus (T2DM). A comprehensive search was conducted in multiple databases, including PubMed and Cochrane Library, to identify relevant randomised controlled trials and observational st...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-05-01
|
| Series: | Indian Journal of Endocrinology and Metabolism |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ijem.ijem_372_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849421003540660224 |
|---|---|
| author | Rifika Bansal Ravi Kant Yogesh Bahurupi Ashwarya Gupta |
| author_facet | Rifika Bansal Ravi Kant Yogesh Bahurupi Ashwarya Gupta |
| author_sort | Rifika Bansal |
| collection | DOAJ |
| description | This systematic review compares the efficacy and safety of gliclazide and glimepiride in managing type 2 diabetes mellitus (T2DM). A comprehensive search was conducted in multiple databases, including PubMed and Cochrane Library, to identify relevant randomised controlled trials and observational studies. Five studies were included based on pre-defined eligibility criteria, focussing on glycaemic control (HbA1c, fasting blood glucose, and post-prandial blood glucose) and safety outcomes like hypoglycaemia and cardiovascular events. Data were extracted and synthesised using established systematic review methodologies, and risk of bias was assessed with Cochrane tools. Both gliclazide and glimepiride effectively reduced HbA1c, but gliclazide showed a lower risk of hypoglycaemia. However, elderly patients using gliclazide had an increased risk of severe hypoglycaemia and fractures. This review indicates that while both drugs are effective, gliclazide may have a safer profile in middle-aged adults, with glimepiride potentially being a better option for older adults. |
| format | Article |
| id | doaj-art-650e179d4e6346a9ab3d764eb9cba9e6 |
| institution | Kabale University |
| issn | 2230-8210 2230-9500 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Endocrinology and Metabolism |
| spelling | doaj-art-650e179d4e6346a9ab3d764eb9cba9e62025-08-20T03:31:34ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002025-05-0129326026710.4103/ijem.ijem_372_24Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic ReviewRifika BansalRavi KantYogesh BahurupiAshwarya GuptaThis systematic review compares the efficacy and safety of gliclazide and glimepiride in managing type 2 diabetes mellitus (T2DM). A comprehensive search was conducted in multiple databases, including PubMed and Cochrane Library, to identify relevant randomised controlled trials and observational studies. Five studies were included based on pre-defined eligibility criteria, focussing on glycaemic control (HbA1c, fasting blood glucose, and post-prandial blood glucose) and safety outcomes like hypoglycaemia and cardiovascular events. Data were extracted and synthesised using established systematic review methodologies, and risk of bias was assessed with Cochrane tools. Both gliclazide and glimepiride effectively reduced HbA1c, but gliclazide showed a lower risk of hypoglycaemia. However, elderly patients using gliclazide had an increased risk of severe hypoglycaemia and fractures. This review indicates that while both drugs are effective, gliclazide may have a safer profile in middle-aged adults, with glimepiride potentially being a better option for older adults.https://journals.lww.com/10.4103/ijem.ijem_372_24gliclazideglimepirideglycaemic controlhypoglycaemiatype 2 diabetes mellitus (t2dm) |
| spellingShingle | Rifika Bansal Ravi Kant Yogesh Bahurupi Ashwarya Gupta Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review Indian Journal of Endocrinology and Metabolism gliclazide glimepiride glycaemic control hypoglycaemia type 2 diabetes mellitus (t2dm) |
| title | Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review |
| title_full | Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review |
| title_fullStr | Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review |
| title_full_unstemmed | Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review |
| title_short | Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review |
| title_sort | efficacy and safety of gliclazide versus glimepiride in t2dm patients a systematic review |
| topic | gliclazide glimepiride glycaemic control hypoglycaemia type 2 diabetes mellitus (t2dm) |
| url | https://journals.lww.com/10.4103/ijem.ijem_372_24 |
| work_keys_str_mv | AT rifikabansal efficacyandsafetyofgliclazideversusglimepirideint2dmpatientsasystematicreview AT ravikant efficacyandsafetyofgliclazideversusglimepirideint2dmpatientsasystematicreview AT yogeshbahurupi efficacyandsafetyofgliclazideversusglimepirideint2dmpatientsasystematicreview AT ashwaryagupta efficacyandsafetyofgliclazideversusglimepirideint2dmpatientsasystematicreview |